IP Library › Granted Patent US 12,551,222
Granted Patent B2
US 12,551,222 · App. 17/923,274 · Granted Feb 17, 2026

Operator-independent histotripsy device

Inventors: Ameer E. Hassan (Harlingen, TX); Yousef Hasan Ahmad Khalili (Dubai, AE)
Assignee: QUANTANOSIS AI, INC.
A61B17/22004A61B2017/0019A61B2017/22028A61B2090/502
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,222
App. No.
17/923,274
Granted
Feb 17, 2026
Kind
B2
Abstract

A histotripsy device may include a headset configured to be mounted to an about a cranium of a human or animal, at least one transducer mounted to the headset and positioned such that, with the headset mounted to and about the cranium, the at least one transducer is positioned over and in contact with at least one temporal or suboccipital region of the cranium, wherein the at least one transducer is configured to emit focused radiation in at an ultrasonic frequency or frequency range, at least one processor, and at least one memory having instructions stored therein executable by the at least one processor to cause the at least one processor to activate the at least one transducer to produce at least one pulse of ultrasonic radiation having a pulse duration of 1 milliseconds or longer.

Claims (34)

1 . A histotripsy device, comprising:

a headset configured to be mounted to a cranium of a human or animal,

at least one transducer mounted to the headset and positioned such that, with the headset mounted to the cranium, the at least one transducer is positioned over and in contact with at least one temporal or suboccipital region of the cranium, the at least one transducer configured to emit focused radiation at an ultrasonic frequency or frequency range,

at least one processor, and

at least one memory having instructions stored therein executable by the at least one processor to cause the at least one processor to activate the at least one transducer to produce at least one pulse of ultrasonic radiation having a pulse duration of 1 milliseconds (ms) or longer, and to activate the at least one transducer to produce between 500 and 1000 pulses,

wherein the at least one transducer is a spherically focused, multi-segment transducer having a 10 cm aperture and a 7.5 cm focal length.

2 . The histotripsy device of claim 1 , wherein the at least one transducer includes:

a first transducer operatively mounted to the headset and positioned such that, with the headset mounted to the cranium, the first transducer is positioned over and in contact with a right temporal region of the cranium, and

a second transducer operatively mounted to the headset and positioned such that, with the headset mounted to the cranium, the second transducer is positioned over and in contact with a left temporal region of the cranium.

3 . The histotripsy device of claim 1 , wherein the at least one transducer includes a third transducer operatively mounted to the headset and positioned such that, with the headset mounted to the cranium, the third transducer is positioned over and in contact with the suboccipital region of the cranium.

4 . The histotripsy device of claim 1 , wherein the headset includes a headband configured to be mounted to and about the cranium.

5 . The histotripsy device of claim 1 , wherein the at least one transducer has an f-number greater than 0.9.

6 . The histotripsy device of claim 1 , wherein the ultrasonic frequency of the emitted radiation is 1 MHz.

7 . The histotripsy device of claim 1 , wherein the pulse duration is 5 ms.

8 . The histotripsy device of claim 1 , wherein the instructions stored in the memory executable by the at least one processor is further configured to cause the at least one processor to activate the at least one transducer to produce the at least one pulse of ultrasonic radiation at a rate greater than 40 Hz.

9 . The histotripsy device of claim 1 , wherein the instructions stored in the memory executable by the at least one processor is further configured to cause the at least one processor to activate the at least one transducer to produce the at least one pulse of ultrasonic radiation for a total insonation time of between 20 and 60 seconds.

10 . The histotripsy device of claim 1 , wherein the histotripsy device is configured to fractionate a clot without adjunctive intravenous thrombolytic medications (ITM).

11 . A histotripsy device, comprising:

a headset configured to be mounted to a cranium of a human or animal,

at least one transducer mounted to the headset and positioned such that, with the headset mounted to the cranium, the at least one transducer is positioned over and in contact with at least one temporal or suboccipital region of the cranium, the at least one transducer configured to emit focused radiation at an ultrasonic frequency or frequency range,

at least one processor, and

at least one memory having instructions stored therein executable by the at least one processor to cause the at least one processor to activate the at least one transducer to produce at least one pulse of ultrasonic radiation having a pulse duration of 1 milliseconds (ms) or longer, and to activate the at least one transducer to produce between 500 and 1000 pulses

wherein the instructions stored in the memory executable by the at least one processor are further configured to cause the at least one processor to activate the at least one transducer to produce the at least one pulse of ultrasonic radiation for a total insonation time of between 20 and 60 seconds.

12 . The histotripsy device of claim 11 , wherein the at least one transducer includes:

a first transducer operatively mounted to the headset and positioned such that, with the headset mounted to the cranium, the first transducer is positioned over and in contact with a right temporal region of the cranium, and

a second transducer operatively mounted to the headset and positioned such that, with the headset mounted to the cranium, the second transducer is positioned over and in contact with a left temporal region of the cranium.

13 . The histotripsy device of claim 11 , wherein the at least one transducer is a spherically focused, multi-segment transducer having a 10 cm aperture and a 7.5 cm focal length.

14 . The histotripsy device of claim 11 , wherein the at least one transducer has an f-number greater than 0.9.

15 . The histotripsy device of claim 11 , wherein the ultrasonic frequency of the emitted radiation is 1 MHz.

16 . The histotripsy device of claim 11 , wherein the pulse duration is 5 ms.

17 . The histotripsy device of claim 11 , wherein the instructions stored in the memory executable by the at least one processor is further configured to cause the at least one processor to activate the at least one transducer to produce the at least one pulse of ultrasonic radiation at a rate greater than 40 Hz.

18 . The histotripsy device of claim 11 , wherein the histotripsy device is configured to fractionate a clot without adjunctive intravenous thrombolytic medications (ITM).

19 . The histotripsy device of claim 11 , wherein the at least one transducer includes a third transducer operatively mounted to the headset and positioned such that, with the headset mounted to the cranium, the third transducer is positioned over and in contact with the suboccipital region of the cranium.

20 . The histotripsy device of claim 11 , wherein the headset includes a headband configured to be mounted to and about the cranium.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2025
From: HASSAN, AMEER E.; KHALILI, YOUSEF HASAN AHMAD
To: QUANTANOSIS.AI, LLC
Reel/Frame 072848/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2025
From: QUANTANOSIS.AI, LLC
To: QUANTANOSIS.AI, INC.
Reel/Frame 072848/0193 →
Continuity (2)
Provisional Application 63064008 · Aug 11, 2020
Related Publication 20230225748A1 · Jul 20, 2023
References Cited (16)
US 20120083717A1 · Alleman · 2012 [cited by examiner]
US 20120083718A1 · Alleman et al. · 2012 [cited by applicant]
US 20150258352A1 · Lin et al. · 2015 [cited by applicant]
US 20160279449A1 · Powers et al. · 2016 [cited by applicant]
US 20180001114A1 · Li · 2018 [cited by applicant]
US 20180146284A1 · Benattar et al. · 2018 [cited by applicant]
US 20180177491A1 · Hynynen et al. · 2018 [cited by applicant]
JP 2014515633A · 2014 [cited by applicant]
JP 2017538545A · 2017 [cited by applicant]
WO 2012125304A1 · 2012 [cited by applicant]
Rubiera et al.; Sonothrombolysis in the Management of Acute Ischemic Stroke; published on Aug. 17, 2012; American Journal of Cardiovasc Drugs vol. 10, p. 5-10 (2010). (Year: 2012). [cited by examiner]
PCT International Search Report and Written Opinion completed by the ISA/US on Oct. 22, 2021 and issued in connection with PCT/US2021/045158. [cited by applicant]
Extended EP Search Report, completed Jul. 26, 2024 and issued in connection with EP Appln. No. 21856494.6. [cited by applicant]
Schafer, Mark, et al., “Design, Development, and Operation of a Low-Intensity Focused Ultrasound Pulsation (LIFUP) System for Clinical Use”, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, IEEE,… [cited by applicant]
Schafer, Mark, et al., “Development of an operator independent ultrasound therapeutic device for stroke treatment”, Ultrasonics Symposium (IUS), 2012 IEEE International, IEEE, Oct. 7, 2012 (Oct. 7, 2012), pp. 1948-1951. [cited by applicant]
Japanese Office Action for corresponding application No. JP2023-507307, dated Feb. 26, 2025. [cited by applicant]